Author

Angel White

University of MinnesotaORCID 0000-0001-8039-3542Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Neuroscience· 2 Biochemistry· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:statistical model· 1

Frequent Co-Authors

Rocío Gómez‐PastoriD· 3 shared Alfonso AraqueiD· 2 shared Rachel H. ManskyiD· 2 shared Ying ZhangiD· 2 shared Amal Fickak· 1 shared Carmen NanclaresiD· 1 shared Cristina Tomás‐ZapicoiD· 1 shared Dahyun YuiD· 1 shared

Activity by Year

2022-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersNeuroscience

Rocío Gómez‐PastorORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

NeurosciencebioRxivPreprintJun 24, 2025

Protein kinase CK2 alpha prime as a dual modulator of neuroimmune signaling and synaptic dysfunction in Tauopathy

Angel White, Peter Gavrilyuk, Persephone Gu…·Rocío Gómez‐Pastor

This study identifies CK2 as a regulator of tauopathy by modulating tau phosphorylation, neuroinflammation, and synaptic dysfunction in mice.

DOI 10.1101/2025.06.24.661391

mouseexperimental assay

𝕏 PostBluesky

BiochemistryACS Chemical NeurosciencePeer-reviewedJun 22, 2024

Identification of CK2α' selective inhibitors by the screening of an allosteric-kinase-inhibitor-like compound library

Deepti J. Mudaliar, Rachel H. Mansky, Angel White…·Rocío Gómez‐Pastor

The paper identifies two CK2α' selective inhibitors from a compound library using a kinase assay, offering potential for treating Huntington's disease.

7 citations

experimental assaydrug response / drug discovery

𝕏 PostBluesky

NeuroscienceActa Neuropathologica CommunicationsPeer-reviewedJun 3, 2022

CK2 alpha prime and alpha-synuclein pathogenic functional interaction mediates synaptic dysregulation in Huntington's disease

Dahyun Yu, Nicole Zarate, Angel White…·Rocío Gómez‐Pastor

This study shows that reducing CK2 in HD mice improves neuroinflammation, HTT aggregation, and motor deficits by reducing synucleinopathy.

29 citations

mousebulk RNA-seq

𝕏 PostBluesky